Total Valuation
Ping An Biomedical has a market cap or net worth of $3.85M. The enterprise value is $9.30M.
Market Cap$3.85M
Enterprise Value$9.30M
Share Statistics
Ping An Biomedical has 24,550,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding24,550,000
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Ping An Biomedical’s return on equity (ROE) is -0.28 and return on invested capital (ROIC) is -23.05%.
Return on Equity (ROE)-0.28
Return on Assets (ROA)-0.19
Return on Invested Capital (ROIC)-23.05%
Return on Capital Employed (ROCE)-0.32
Revenue Per Employee4.88M
Profits Per Employee-1.83M
Employee Count7
Asset Turnover0.50
Inventory Turnover75.13
Valuation Ratios
The current PE Ratio of Ping An Biomedical is ―. Ping An Biomedical’s PEG ratio is 0.00.
PE Ratio―
PS Ratio0.00
PB Ratio0.00
Price to Fair Value0.00
Price to FCF0.00
Price to Operating Cash Flow―
PEG Ratio0.00
Income Statement
In the last 12 months, Ping An Biomedical had revenue of 34.15M and earned -12.83M in profits. Earnings per share was 0.00.
Revenue34.15M
Gross Profit949.50K
Operating Income-14.70M
Pretax Income-14.68M
Net Income-12.83M
EBITDA-14.37M
Earnings Per Share (EPS)0.00
Cash Flow
In the last 12 months, operating cash flow was ― and capital expenditures ―, giving a free cash flow of ― billion.
Operating Cash Flow―
Free Cash Flow―
Free Cash Flow per Share―
Dividends & Yields
Ping An Biomedical pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.45
52-Week Price Change-95.27%
50-Day Moving Average1.16
200-Day Moving Average―
Relative Strength Index (RSI)33.23
Average Volume (3m)1.95M
Important Dates
Ping An Biomedical upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
Ping An Biomedical as a current ratio of 2.76, with Debt / Equity ratio of ―
Current Ratio2.76
Quick Ratio2.74
Debt to Market Cap0.00
Net Debt to EBITDA-0.65
Interest Coverage Ratio-47.88
Taxes
In the past 12 months, Ping An Biomedical has paid -1.86M in taxes.
Income Tax-1.86M
Effective Tax Rate0.13
Enterprise Valuation
Ping An Biomedical EV to EBITDA ratio is -0.65, with an EV/FCF ratio of -1.45.
EV to Sales0.27
EV to EBITDA-0.65
EV to Free Cash Flow-1.45
EV to Operating Cash Flow-1.45
Balance Sheet
Ping An Biomedical has ― in cash and marketable securities with ― in debt, giving a net cash position of ― billion.
Cash & Marketable Securities―
Total Debt―
Net Cash―
Net Cash Per Share―
Tangible Book Value Per Share$0.00
Margins
Gross margin is ―, with operating margin of -43.05%, and net profit margin of -37.57%.
Gross Margin―
Operating Margin-43.05%
Pretax Margin-43.00%
Net Profit Margin-37.57%
EBITDA Margin-42.09%
EBIT Margin-42.10%
Analyst Forecast
The average price target for Ping An Biomedical is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―